114 related articles for article (PubMed ID: 15972142)
1. [Long distance vectorette PCR for detecting translocation of IgH gene in switch regions of patients with multiple myeloma].
Guo C; Huo J; Jiang H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):460-3. PubMed ID: 15972142
[TBL] [Abstract][Full Text] [Related]
2. Isolation and characterisation of recombination events involving immunoglobulin heavy chain switch regions in multiple myeloma using long distance vectorette PCR (LDV-PCR).
Proffitt J; Fenton J; Pratt G; Yates Z; Morgan G
Leukemia; 1999 Jul; 13(7):1100-7. PubMed ID: 10400427
[TBL] [Abstract][Full Text] [Related]
3. Genomic characterization of the chromosomal breakpoints of t(4;14) of multiple myeloma suggests more than one possible aetiological mechanism.
Fenton JA; Pratt G; Rawstron AC; Sibley K; Rothwell D; Yates Z; Dring A; Richards SJ; Ashcroft AJ; Davies FE; Owen RG; Child JA; Morgan GJ
Oncogene; 2003 Feb; 22(7):1103-13. PubMed ID: 12592397
[TBL] [Abstract][Full Text] [Related]
4. Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma.
Bergsagel PL; Chesi M; Nardini E; Brents LA; Kirby SL; Kuehl WM
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):13931-6. PubMed ID: 8943038
[TBL] [Abstract][Full Text] [Related]
5. Insertion of excised IgH switch sequences causes overexpression of cyclin D1 in a myeloma tumor cell.
Gabrea A; Bergsagel PL; Chesi M; Shou Y; Kuehl WM
Mol Cell; 1999 Jan; 3(1):119-23. PubMed ID: 10024885
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines.
Chesi M; Bergsagel PL; Brents LA; Smith CM; Gerhard DS; Kuehl WM
Blood; 1996 Jul; 88(2):674-81. PubMed ID: 8695815
[TBL] [Abstract][Full Text] [Related]
7. Rapid amplification of immunoglobulin heavy chain switch (IGHS) translocation breakpoints using long-distance inverse PCR.
Sonoki T; Willis TG; Oscier DG; Karran EL; Siebert R; Dyer MJ
Leukemia; 2004 Dec; 18(12):2026-31. PubMed ID: 15496980
[TBL] [Abstract][Full Text] [Related]
8. IgH translocations in multiple myeloma: a nearly universal event that rarely involves c-myc.
Bergsagel PL; Nardini E; Brents L; Chesi M; Kuehl WM
Curr Top Microbiol Immunol; 1997; 224():283-7. PubMed ID: 9308253
[TBL] [Abstract][Full Text] [Related]
9. Complex biallelic IGH rearrangements in IgM-expressing Z-138 cell line: Involvement of downstream immunoglobulin class switch recombination.
Guikema JE; Fenton JA; de Boer C; Kleiverda K; Brink AA; Raap AK; Estrov Z; Schuuring E; Kluin PM
Genes Chromosomes Cancer; 2005 Feb; 42(2):164-9. PubMed ID: 15543623
[TBL] [Abstract][Full Text] [Related]
10. Combined polymerase chain reaction methods to detect c-myc/IgH rearrangement in childhood Burkitt's lymphoma for minimal residual disease analysis.
Busch K; Borkhardt A; Wössmann W; Reiter A; Harbott J
Haematologica; 2004 Jul; 89(7):818-25. PubMed ID: 15257933
[TBL] [Abstract][Full Text] [Related]
11. Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma.
Iida S; Rao PH; Butler M; Corradini P; Boccadoro M; Klein B; Chaganti RS; Dalla-Favera R
Nat Genet; 1997 Oct; 17(2):226-30. PubMed ID: 9326949
[TBL] [Abstract][Full Text] [Related]
12. Light-chain only multiple myeloma is due to the absence of functional (productive) rearrangement of the IgH gene at the DNA level.
Magrangeas F; Cormier ML; Descamps G; Gouy N; Lodé L; Mellerin MP; Harousseau JL; Bataille R; Minvielle S; Avet-Loiseau H
Blood; 2004 May; 103(10):3869-75. PubMed ID: 14715636
[TBL] [Abstract][Full Text] [Related]
13. Insertional events as well as translocations may arise during aberrant immunoglobulin switch recombination in a patient with multiple myeloma.
Pratt G; Fenton JA; Davies FE; Rawstron AC; Richards SJ; Collins JE; Owen RG; Jack AS; Smith GM; Morgan GJ
Br J Haematol; 2001 Feb; 112(2):388-91. PubMed ID: 11167836
[TBL] [Abstract][Full Text] [Related]
14. Fluorescence in situ hybridization analysis shows the frequent occurrence of 14q32.3 rearrangements with involvement of immunoglobulin switch regions in myeloma cell lines.
Kuipers J; Vaandrager JW; Weghuis DO; Pearson PL; Scheres J; Lokhorst HM; Clevers H; Bast BJ
Cancer Genet Cytogenet; 1999 Mar; 109(2):99-107. PubMed ID: 10087940
[TBL] [Abstract][Full Text] [Related]
15. Combined molecular diagnosis of B-cell lymphomas with t(11;14)(q13;q32) or t(14;18)(q32;q21) using multiplex- and long distance inverse-polymerase chain reaction.
Vieira L; Martinho A; Antunes O; Silva E; Ambrósio AP; Geraldes MC; Nascimento R; Silva C; Pereira JM; Júnior EC; Jordan P
Diagn Mol Pathol; 2008 Jun; 17(2):73-81. PubMed ID: 18382373
[TBL] [Abstract][Full Text] [Related]
16. Light-chain plasma cell myeloma caused by 14q32/IGH translocation and loss of the other allele.
Nishio Y; Sakai H; Saiki Y; Uchida A; Uemura Y; Matsunawa M; Isobe Y; Kato M; Tomita N; Miura I
Int J Hematol; 2019 May; 109(5):572-577. PubMed ID: 30887274
[TBL] [Abstract][Full Text] [Related]
17. Establishment and characterization of a new human myeloma cell line, KYdelta-1, producing the delta/kappa type immunoglobulin.
Ueda C; Yamada H; Akasaka T; Ohmori K; Sasada M; Uchiyama T; Ohno H
Cancer Genet Cytogenet; 2001 Oct; 130(1):42-50. PubMed ID: 11672773
[TBL] [Abstract][Full Text] [Related]
18. Characterization of IGH locus breakpoints in multiple myeloma indicates a subset of translocations appear to occur in pregerminal center B cells.
Walker BA; Wardell CP; Johnson DC; Kaiser MF; Begum DB; Dahir NB; Ross FM; Davies FE; Gonzalez D; Morgan GJ
Blood; 2013 Apr; 121(17):3413-9. PubMed ID: 23435460
[TBL] [Abstract][Full Text] [Related]
19. Differential nuclear organization of translocation-prone genes in nonmalignant B cells from patients with t(14;16) as compared with t(4;14) or t(11;14) myeloma.
Martin LD; Harizanova J; Righolt CH; Zhu G; Mai S; Belch AR; Pilarski LM
Genes Chromosomes Cancer; 2013 Jun; 52(6):523-37. PubMed ID: 23460268
[TBL] [Abstract][Full Text] [Related]
20. Recurrent immunoglobulin gene translocations identify distinct molecular subtypes of myeloma.
Chesi M; Kuehl WM; Bergsagel PL
Ann Oncol; 2000; 11 Suppl 1():131-5. PubMed ID: 10707795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
